Madrigal Expands MASH Pipeline with $60 Million Ribo siRNA Deal

February 16, 2026

FDA Gives the Green Light to Omeros’ Cell Transplant Drug Yartemlea

January 13, 2026

Roche relying on Polivy’s $2B potential to weather biosimilar storm

August 10, 2021

Must Read

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

May 8, 2026

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

May 8, 2026

Is Green Biotech the Future of Sustainable Drug Development?

May 6, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

Takeda Reports Phase 2/3 Data Showing TAK-881 Comparable to HyQvia in Primary Immunodeficiency Disease

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Teva Pens Deal Worth Over $700M to Buy Emalex

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Is Green Biotech the Future of Sustainable Drug Development?

Top 10 High-Impact Careers Defining the Future of Life Sciences

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Clinical

Vertex Presses Pause on CF Study, Reports Major Write-Down

Editor Picks

Madrigal Expands MASH Pipeline with $60 Million Ribo siRNA Deal

FDA Gives the Green Light to Omeros’ Cell Transplant Drug Yartemlea

Roche relying on Polivy’s $2B potential to weather biosimilar storm

Must Read

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Is Green Biotech the Future of Sustainable Drug Development?

Hot Topics

About Us

Follow Us